Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GB226 in Relapsed/Refractory Peripheral T-cell Lymphoma
CTR20180442Phase 2Active
- Sponsor
- Jacobio Pharmaceuticals
- Start
- Apr 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of geptanolimab in peripheral T-cell lymphoma (PTCL), sponsored by Jacobio Pharmaceuticals. Started Apr 2018; status: active.
02
Drugs
geptanolimab
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on CTR20180442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180442.